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HIV/TB therapy. The duration of therapy ranged from six
months to two years. Each of the three subjects highlighted
the difﬁculties to adequately manage the HIV/TB patient
and the infrastructure needed to support this level of care.
With the HIV/AIDS pandemic threatening to destabilize con-
trol of TB we should be supporting initiatives to improve TB
and HIV programs in resource poor settings with a focus on
preventive measures.
doi:10.1016/j.ijid.2008.05.1367
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Background: TB is the most common and serious HIV
related complication. It is estimated that about half of TB
cases in Uganda are co-infected with HIV and about 30%
of the HIV-related deaths are attributed to TB. However,
HIV and TB diagnosis programs are not traditionally inte-
grated. The recently launched national policy guidelines
for TB/HIV collaborative activities are aimed at integrat-
ing diagnosis, care and treatment for TB/HIV co-infected
patients. The Mulago-Mbarara Teaching Hospitals’ Joint AIDS
Program (MJAP) has been providing integrated routine HIV
testing and counselling, and TB screening for medical inpa-
tients in Mulago hospital since March 2005.
Method: All patients on medical wards in Mulago are
routinely offered HIV testing and counselling. Patients pre-
senting with a history of cough for more than three weeks
are also screened for TB by sputum microscopy. Patients
with HIV infection are started on cotrimoxazole prophylaxis,
those who are co-infected with TB and HIV are referred to
the TB HIV clinic were they receive both TB and HIV care
and treatment. We analysed data for 379 patients to assess
the number of new TB and HIV infections identiﬁed.
Result: Among the 379 patients, 200 (53%) did not know
their HIV/TB status on admission, and received both HIV
testing and TB screening. Of these, 24 (11%) were co-
infected with TB and HIV, 70 (35%) had HIV infection alone
while 22 (11%) had TB infection alone. Out of the 159
patients who were known to be HIV-Infected on admission,
40 (25%) had TB infection. Overall, 64 out of the 379 patients
(17%) were co-infected with TB and HIV. Among the 253 HIV
infected patients 64 (25%) had smear positive TB.
Conclusion: Integration of TB and HIV diagnosis is feasible
and provides an opportunity for appropriate linkage to care
for TB-HIV co-infected patients.
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